Cargando…

Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors

The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Pávová, Marcela, Reyes-Gutiérrez, Paul Eduardo, Kozák, Jaroslav, Dobiaš, Juraj, Yurenko, Yevgen, Lepšík, Martin, Teplý, Filip, Weber, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102027/
https://www.ncbi.nlm.nih.gov/pubmed/37055553
http://dx.doi.org/10.1038/s41598-023-33263-3
_version_ 1785025614516846592
author Pávová, Marcela
Reyes-Gutiérrez, Paul Eduardo
Kozák, Jaroslav
Dobiaš, Juraj
Yurenko, Yevgen
Lepšík, Martin
Teplý, Filip
Weber, Jan
author_facet Pávová, Marcela
Reyes-Gutiérrez, Paul Eduardo
Kozák, Jaroslav
Dobiaš, Juraj
Yurenko, Yevgen
Lepšík, Martin
Teplý, Filip
Weber, Jan
author_sort Pávová, Marcela
collection PubMed
description The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 replication. Here, we identified helquat-based compounds as a new class of anti-HIV-1 inhibitors that inhibit HIV-1 replication at the stage of reverse transcription and provirus expression. Using Taq polymerase stop and FRET melting assays, we have demonstrated their ability to stabilize G-quadruplexes in the HIV-1 long-terminal repeat sequence. Moreover, these compounds were not binding to the general G-rich region, but rather to G-quadruplex-forming regions. Finally, docking and molecular dynamics calculations indicate that the structure of the helquat core greatly affects the binding mode to the individual G-quadruplexes. Our findings can provide useful information for the further rational design of inhibitors targeting G-quadruplexes in HIV-1.
format Online
Article
Text
id pubmed-10102027
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101020272023-04-15 Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors Pávová, Marcela Reyes-Gutiérrez, Paul Eduardo Kozák, Jaroslav Dobiaš, Juraj Yurenko, Yevgen Lepšík, Martin Teplý, Filip Weber, Jan Sci Rep Article The secondary structure of nucleic acids containing quartets of guanines, termed G-quadruplexes, is known to regulate the transcription of many genes. Several G-quadruplexes can be formed in the HIV-1 long terminal repeat promoter region and their stabilization results in the inhibition of HIV-1 replication. Here, we identified helquat-based compounds as a new class of anti-HIV-1 inhibitors that inhibit HIV-1 replication at the stage of reverse transcription and provirus expression. Using Taq polymerase stop and FRET melting assays, we have demonstrated their ability to stabilize G-quadruplexes in the HIV-1 long-terminal repeat sequence. Moreover, these compounds were not binding to the general G-rich region, but rather to G-quadruplex-forming regions. Finally, docking and molecular dynamics calculations indicate that the structure of the helquat core greatly affects the binding mode to the individual G-quadruplexes. Our findings can provide useful information for the further rational design of inhibitors targeting G-quadruplexes in HIV-1. Nature Publishing Group UK 2023-04-13 /pmc/articles/PMC10102027/ /pubmed/37055553 http://dx.doi.org/10.1038/s41598-023-33263-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pávová, Marcela
Reyes-Gutiérrez, Paul Eduardo
Kozák, Jaroslav
Dobiaš, Juraj
Yurenko, Yevgen
Lepšík, Martin
Teplý, Filip
Weber, Jan
Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
title Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
title_full Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
title_fullStr Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
title_full_unstemmed Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
title_short Helquat dyes targeting G-quadruplexes as a new class of anti-HIV-1 inhibitors
title_sort helquat dyes targeting g-quadruplexes as a new class of anti-hiv-1 inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102027/
https://www.ncbi.nlm.nih.gov/pubmed/37055553
http://dx.doi.org/10.1038/s41598-023-33263-3
work_keys_str_mv AT pavovamarcela helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT reyesgutierrezpauleduardo helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT kozakjaroslav helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT dobiasjuraj helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT yurenkoyevgen helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT lepsikmartin helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT teplyfilip helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors
AT weberjan helquatdyestargetinggquadruplexesasanewclassofantihiv1inhibitors